Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.
about
Functional imaging in muscular diseasesIn vivo magnetic resonance spectroscopy: basic methodology and clinical applicationsRepeatability of (31) P MRSI in the human brain at 7 T with and without the nuclear Overhauser effect.Changes in tissue water content measured with multiple-frequency bioimpedance and metabolism measured with 31P-MRS during progressive forearm exercise.Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical TrialsEffect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trialIn vivo chemical exchange saturation transfer imaging of creatine (CrCEST) in skeletal muscle at 3T.Increased oxidative metabolism in the Li-Fraumeni syndromeA complex rearrangement in GBE1 causes both perinatal hypoglycemic collapse and late-juvenile-onset neuromuscular degeneration in glycogen storage disease type IV of Norwegian forest cats.The feasibility of measuring phosphocreatine recovery kinetics in muscle using a single-shot (31)P RARE MRI sequence.An in vivo rodent model of contraction-induced injury and non-invasive monitoring of recoveryRapid 3D-imaging of phosphocreatine recovery kinetics in the human lower leg muscles with compressed sensing.Modular MR-compatible lower leg exercise device for whole-body scanners.Method for high-resolution imaging of creatine in vivo using chemical exchange saturation transfer.Insulin resistance and impaired mitochondrial function in obese adolescent girls.Metabolic myopathies: functional evaluation by different exercise testing approaches.Tumour-induced osteomalacia.A comparison of voluntary and electrically induced contractions by interleaved 1H- and 31P-NMRS in humans.Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy.Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia.International Workshop:: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16-18 November 2016, Rome, Italy.Muscle metabolic alterations assessed by 31-phosphorus magnetic resonance spectroscopy in mild Becker muscular dystrophy.Splitting of Pi and other ³¹P NMR anomalies of skeletal muscle metabolites in canine muscular dystrophy.
P2860
Q30470355-75E593CC-B5DA-4ED7-9B03-0C989C7506EEQ30482507-D582E1F8-2342-4124-AFED-3EF672D693DFQ31030888-A08CB0E3-4A7B-4E4C-8000-C566AC0AF4EFQ31045990-CE4B9C9E-7B4B-426B-ACF5-C4CD3B3E137FQ31142754-D95E2A22-3D3A-418B-BB2A-F0CF416A36F6Q33621897-D4F30DFA-BA09-4293-B98F-F3365C4F947DQ33763798-8851DC0E-E949-4773-81C0-CC744A03317BQ34008143-D4D08E10-9373-4EDD-946A-34E520BC8C31Q34606916-55418E77-1ECF-4F7C-85E8-B23DF9B0575AQ35046380-DF3CA6F2-6844-4150-9A5D-511DC8B4BC46Q35392496-8F3C8BB5-76EB-4F63-B46B-372FC37FE756Q36418494-70CF7E81-7E59-460B-95D8-F19B7396C687Q36887305-0A3D2A7C-1642-426B-B536-FAD79A9ECB4AQ37049820-B1846535-95DD-4BA9-9628-5F7D26E3C519Q37617629-3136FC8C-810B-4BCD-A273-F4735A2EA0EAQ37849644-2697DE6B-C809-4967-BA2A-F427F7D9C4B2Q39432298-8E792251-B569-4328-8BC9-3AE3C8975363Q44304888-0F52971F-F57C-4B36-9128-CD649A9476F1Q44337026-4C755509-2730-4261-A9C2-C2FA95A90FA9Q46496644-FDD5915D-A4A1-4D87-ABBA-FABA128C2BFBQ48566835-422E645F-3F92-44A3-BB66-A47849D7E6E1Q51852614-96AFAE18-E9BB-4923-9ACE-37C182C6CA18Q52621969-6B824CD4-3CB9-447A-9AB4-8F6973C08A83
P2860
Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.
@ast
Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.
@en
Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.
@nl
type
label
Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.
@ast
Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.
@en
Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.
@nl
prefLabel
Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.
@ast
Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.
@en
Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.
@nl
P2093
P2860
P1433
P1476
Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.
@en
P2093
P2860
P304
P356
10.1002/1097-4598(200009)23:9<1316::AID-MUS2>3.0.CO;2-I
P577
2000-09-01T00:00:00Z